Overview

A Multicenter, Open-Label, Withdrawal and Treatment Trial Assessing the Efficacy, Safety, and Tolerability of Doses of CERC-801 in Subjects With SLC35A2-CDG

Status:
Not yet recruiting
Trial end date:
2025-03-31
Target enrollment:
Participant gender:
Summary
This is a multicenter, open-label, withdrawal and treatment study assessing the efficacy, safety, and tolerability of CERC-801 in subjects with SLC35A2-CDG.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Eva Morava-Kozicz